Provisions for post-trial care {30}
ADVERSE EVENTS
No long-term risks of using the device are known or expected but these, if present, will be observed within this study. For all subjects who participate in this study, all AEs/ADEs and serious adverse events (SAEs) as well as other safety parameters will be followed up 14 days following trial cessation.